Nomura Asset Management Co. Ltd. Lowers Holdings in Kenvue Inc. (NYSE:KVUE)

Nomura Asset Management Co. Ltd. reduced its position in shares of Kenvue Inc. (NYSE:KVUE) by 9.0% in the fourth quarter, Holdings Channel reports. The firm owned 3,955,483 shares of the company’s stock after selling 389,243 shares during the period. Nomura Asset Management Co. Ltd.’s holdings in Kenvue were worth $84,450,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. Providence Capital Advisors LLC bought a new stake in Kenvue during the fourth quarter valued at $2,557,000. Norges Bank bought a new position in Kenvue in the 4th quarter worth about $521,348,000. Blair William & Co. IL raised its holdings in shares of Kenvue by 0.9% in the 4th quarter. Blair William & Co. IL now owns 194,250 shares of the company’s stock valued at $4,147,000 after acquiring an additional 1,755 shares in the last quarter. Caisse Des Depots ET Consignations bought a new stake in shares of Kenvue during the 4th quarter valued at about $4,978,000. Finally, NEOS Investment Management LLC grew its holdings in shares of Kenvue by 31.5% during the fourth quarter. NEOS Investment Management LLC now owns 103,849 shares of the company’s stock worth $2,217,000 after purchasing an additional 24,888 shares in the last quarter. Institutional investors own 97.64% of the company’s stock.

Kenvue Price Performance

KVUE opened at $23.52 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69. Kenvue Inc. has a 1 year low of $17.67 and a 1 year high of $24.46. The stock’s 50 day simple moving average is $22.27 and its 200 day simple moving average is $22.46. The firm has a market cap of $44.95 billion, a price-to-earnings ratio of 44.38, a PEG ratio of 2.62 and a beta of 1.25.

Kenvue (NYSE:KVUE) last issued its earnings results on Thursday, February 6th. The company reported $0.26 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. As a group, analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Wednesday, February 12th were paid a dividend of $0.205 per share. This represents a $0.82 annualized dividend and a dividend yield of 3.49%. The ex-dividend date of this dividend was Wednesday, February 12th. Kenvue’s dividend payout ratio (DPR) is 154.72%.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on KVUE shares. Evercore ISI started coverage on shares of Kenvue in a research note on Monday. They issued an “in-line” rating and a $25.00 target price on the stock. Canaccord Genuity Group lifted their price objective on shares of Kenvue from $24.00 to $29.00 and gave the stock a “buy” rating in a report on Wednesday, March 5th. Citigroup reduced their target price on Kenvue from $25.00 to $21.00 and set a “neutral” rating on the stock in a research note on Wednesday, January 15th. Deutsche Bank Aktiengesellschaft lowered Kenvue from a “buy” rating to a “hold” rating and dropped their price target for the stock from $25.00 to $24.00 in a research note on Thursday, December 12th. Finally, UBS Group reduced their price objective on Kenvue from $23.00 to $21.00 and set a “neutral” rating on the stock in a research report on Friday, February 7th. One research analyst has rated the stock with a sell rating, eight have given a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, Kenvue has a consensus rating of “Hold” and a consensus price target of $24.00.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.